Cowen Inc’s Exelixis EXEL Stock Holding History

Cowen Inc’s Portfolio EXEL Stock Details EXEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-17,500	Closed	-$70K	–	241
2016 Q1	$70K	Buy	17,500 +3,900	+29%	+$16.5K	﹤0.01%	239
2015 Q4	$77K	Buy	+13,600	New	+$76.1K	0.01%	284

Other funds holding EXEL

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Cowen Inc's EXEL Position: Q2 2016 in Review

Cowen Inc sold out of Exelixis (EXEL) in Q2 2016, closing a stake of 17,500 shares — an estimated $70K sold.

Cowen Inc first reported a position in EXEL in Q4 2015 and held it in 2 quarters. The position peaked at $77K in Q4 2015. 166 funds tracked by Wall St. Rank hold EXEL as of Q2 2016.

Cowen Inc reported no remaining Exelixis position as of Q2 2016 after selling out during the quarter.
Cowen Inc sold 17,500 Exelixis shares in Q2 2016, an estimated $70K.
Cowen Inc first reported a position in Exelixis in Q4 2015 and held it in 2 quarters.
Cowen Inc's Exelixis position peaked at $77K in Q4 2015.
166 funds tracked by Wall St. Rank held Exelixis as of Q2 2016.

Based on Cowen Inc's 13F filing for Q2 2016, filed 10 Aug 2016.